Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2 Breast 2 Thoracic 1 Head & Neck 1 Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 1

Interventions

lutetium Lu 177 dotatate 6 Everolimus 6 lanreotide 5 anlotinib 5 Temozolomide 5 Injections 4 Dexmedetomidine 4 Cisplatin 4 surufatinib 3 Thyrotropin Alfa 3 Sodium Chloride 3 Saline Solution 3 Blood Specimen Collection 3 177Lu-octreotide, DOTA(0)-Tyr(3)- 3 (177)Lu-DOTA-EB-TATE 3 sintilimab 2 penpulimab 2 cabozantinib 2 Surgical Procedures, Operative 2 Sorafenib 2 Rosiglitazone 2 Radiotherapy 2 Radiofrequency Ablation 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Nivolumab 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Lymph Node Excision 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Histocompatibility Testing × Endocrine × Clear all

NCT01774279 2021-01-05

iNATT

Velindre NHS Trust

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡